Long-term impact of scheduled regular endoscopic interventions for patients with primary sclerosing cholangitis
In conclusion, we report the outcome data of a scheduled follow-up ERCP program for patients with PSC in an experienced high-volume endoscopy center. Our data suggest the initiation of multicenter randomized controlled prospective trials to explore the full potential of regular endoscopic follow-up treatment as a strategy to prevent disease progression in patients with PSC.
Authors
- Hilmar Berger (ORCID: https://orcid.org/0000-0002-6304-4946)
- Alexander Wree (ORCID: https://orcid.org/0000-0002-2968-1335)
- Silke Leonhardt (ORCID: https://orcid.org/0000-0001-7683-2733)
- Jule Marie Nicklaus
- Burcin Özdirik (ORCID: https://orcid.org/0000-0002-8885-737X)
- T Müller (ORCID: https://orcid.org/0000-0002-1129-5591)
- Michael Sigal (ORCID: https://orcid.org/0000-0003-4772-0761)
- Andreas Adler (ORCID: https://orcid.org/0000-0003-0191-9839)
- Volker Penndorf
- Daniel Schmidt
- W Veltzke-Schlieker
- Frank Tacke (ORCID: https://orcid.org/0000-0001-6206-0226)
Institutions
- Max Delbrück Center (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/hc9.0000000000000494
- Citations
- 5
- Primary Topic
- Gallbladder and Bile Duct Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Berlin Institute of Health